Viable | Cell salvage reinfused group | Control group | P-value |
---|---|---|---|
(n = 61) | (n = 64) | ||
Hemoglobin (g/l) | |||
 Preoperative | 137 (130–142) | 136 (131–143) | .694a |
 Day 1 | 108 (99–117) | 105 (94–112) | .112a |
Hematocrit (%) | |||
 Preoperative | 41 (40–42) | 41 (39–43) | .919a |
 Day 1 | 32 (27–35) | 32 (28–35) | .804a |
Estimated blood loss (ml) | 846 (623–1230) | 1195 (861 to 1474) | .002a |
Reinfused blood (ml) | 300 (200–750) | – |  |
Allogeneic RBC transfused (units) | 2.0 (1.5–2.0) | 1.5 (1.5–2.0) | .630a |
Allogeneic RBC transfused, n (%) | 7 (11.5%) | 17 (26.6%) | .041b |
Plasma transfused (ml) | 300 (163–1712) | 200 (200–400) | .896a |
Plasma transfused, n (%) | 4 (6.6%) | 5 (7.8%) | 1.000b |
Duration of operation (min) | 159 (143–180) | 156 (130–175) | .128a |
Length of hospitalization (days) | 11 (9–14) | 12 (10–18) | .045a |